As Puerto Rico prepares for gubernatorial elections, the candidates’ views on cannabis have come into focus. While recreational use remains illegal, the leading contenders – Jenniffer González, Jesús Manuel Ortiz, and Juan Dalmau – have all expressed support for varying levels of cannabis reform, ranging from expanding the medical cannabis industry to decriminalization.
Results for: Medical Marijuana
Trulieve Cannabis Corp., a leading cannabis company in the U.S., announced the opening of four new medical cannabis dispensaries in Florida, expanding its reach to the panhandle, Space Coast and Tampa Bay regions. The grand opening celebrations will take place on September 6th at all locations, featuring music, specials, discounts, and opportunities to learn about adult cannabis legalization in Florida.
This article explores the varying cannabis laws across different countries. While Poland maintains a zero-tolerance policy, the Philippines is debating the legalization of medical marijuana, and Sri Lanka is attracting investments in the cannabis industry.
The Czech Republic is grappling with cannabis legislation, with the governing coalition supporting medical marijuana expansion but showing hesitation towards full recreational legalization. While a draft bill proposing a regulated market similar to Canada and some US states exists, its future remains uncertain. The bill faces internal review and potential revisions before reaching the European Commission, highlighting the complexity of the process.
Mothers of children with epilepsy in Brazil have been instrumental in advocating for the legalization and free access to cannabidiol (CBD)-based medicines. Their decade-long fight has resulted in groundbreaking changes in São Paulo, where CBD-based medicines are now available free of charge in public and private health facilities. This victory is a testament to their unwavering commitment to their children’s health and the potential of CBD as a life-saving treatment.
Aurora Cannabis has partnered with Vectura to launch a CBD lozenge, providing an alternative consumption method for medical cannabis patients. The company also reports strong international sales growth and improved financial performance, showcasing its commitment to innovative products and expansion.
New Zealand-based medical marijuana company Rua Biosciences has expanded into the Australian market with its dried flower product, Rua Rau Hiwa. The company leverages its unique genetics, cultivated in New Zealand, to provide high-quality medical cannabis solutions to patients in Australia. The move reflects the burgeoning Australian medical marijuana market, which has seen a significant rise in patient numbers and cannabis imports.
Bioxyne Limited’s subsidiary, Breathe Life Sciences (BLS), has achieved a significant milestone by becoming the first Australian company to manufacture and deliver pharmaceutical-grade cannabis edibles. These gummies, certified by the TGA, mark a major step forward in the domestic production and availability of medicinal marijuana products in Australia. The company has already secured substantial orders and anticipates significant growth in the market for cannabis edibles.
Trulieve Cannabis Corp. is opening a new medical cannabis dispensary in New Port Richey, Florida, offering a wide selection of products and services to patients in Pasco County. The grand opening celebration will take place on August 16th and feature music, discounts, and patient education opportunities. Trulieve also advocates for the legalization of adult cannabis use in Florida.
A groundbreaking study spanning two decades suggests that cannabis users may experience improved heart attack outcomes compared to non-users, contradicting the long-held belief that cannabis worsens heart health. The research, published in the Archives of Medical Science Atherosclerosis Diseases, highlights a potential ‘cannabis paradox’ and underscores the need for further investigation into the complex relationship between cannabis and cardiovascular health.